1910 Genetics
1910 Genetics is a biotechnology company that advances small and large molecule drug discovery using a multimodal AI platform integrated with laboratory automation. Their proprietary platform combines computational data, wet lab proxy biological data, and wet lab ground truth biological data to deliver novel drug candidates and software solutions to leading pharmaceutical and technology partners. The company also advances its internal pipeline targeting neurological, autoimmune diseases, and cancer. Their vision is to make undruggable targets druggable by reimagining the drug discovery process with AI, overcoming fragmented data, and leveraging massive parallel data, AI, and lab automation in an iterative loop. 1910 Genetics operates with a business model focused on partnerships and therapeutic asset development, positioning itself as a technology infrastructure layer for tech-enabled drug discovery at scale.
1910 Genetics
1910 Genetics is a biotechnology company that advances small and large molecule drug discovery using a multimodal AI platform integrated with laboratory automation. Their proprietary platform combines computational data, wet lab proxy biological data, and wet lab ground truth biological data to deliver novel drug candidates and software solutions to leading pharmaceutical and technology partners. The company also advances its internal pipeline targeting neurological, autoimmune diseases, and cancer. Their vision is to make undruggable targets druggable by reimagining the drug discovery process with AI, overcoming fragmented data, and leveraging massive parallel data, AI, and lab automation in an iterative loop. 1910 Genetics operates with a business model focused on partnerships and therapeutic asset development, positioning itself as a technology infrastructure layer for tech-enabled drug discovery at scale.